scispace - formally typeset
K

Koen Brusselmans

Researcher at Katholieke Universiteit Leuven

Publications -  22
Citations -  7251

Koen Brusselmans is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Cancer cell & Cell growth. The author has an hindex of 18, co-authored 22 publications receiving 6801 citations. Previous affiliations of Koen Brusselmans include Catholic University of Leuven.

Papers
More filters
Journal ArticleDOI

Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.

TL;DR: It is shown that hypoxia and hypoglycaemia reduce proliferation and increase apoptosis in wild-type (Hif-1α+/+) embryonic stem (ES) cells, but not in ES cells with inactivated HIF-1 α genes (HIF- 1α−/−), suggesting that there are at least two different adaptive responses to being deprived of oxygen and nutrients.
Journal ArticleDOI

Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice

TL;DR: It is reported that loss of the hypoxia-inducible transcription factor-2 α (HIF-2α) caused fatal RDS in neonatal mice due to insufficient surfactant production by alveolar type 2 cells and the pneumotrophic effect of VEGF may have therapeutic potential for lung maturation in preterm infants.
Journal ArticleDOI

De novo Lipogenesis Protects Cancer Cells from Free Radicals and Chemotherapeutics by Promoting Membrane Lipid Saturation

TL;DR: Evidence is provided that shifting lipid acquisition from lipid uptake toward de novo lipogenesis dramatically changes membrane properties and protects cells from both endogenous and exogenous insults, and provides a rationale for the use of lipogenesis inhibitors as antineoplastic agents and as chemotherapeutic sensitizers.
Journal ArticleDOI

Increased lipogenesis in cancer cells: new players, novel targets

TL;DR: Not only fatty acid synthase, but in fact all key enzymes involved in fatty acid synthesis as well as key metabolic regulators are potential targets for antineoplastic intervention.